Dultz, Georg http://orcid.org/0000-0003-0775-0907
Müller, Tobias
Petersen, Jörg
Mauss, Stefan
Zimmermann, Tim
Muche, Marion
Simon, Karl-Georg
Berg, Thomas
Zeuzem, Stefan
Hüppe, Dietrich
Böker, Klaus
Wedemeyer, Heiner
Welzel, Tania M.
Günther, Rainer
Hinrichsen, Holger
Heyne, Renate
Roth, Johannes
Goeser, Tobias
Ullrich, Rainer
John, Christine
Hofmann, Wolf Peter
Teuber, Gerlinde
Möller, Hjördis
Baumgarten, Axel
Schwenzer, Jeannette
Pathil, Anita
Kraus, Michael R.
Weber, Andreas
Jung, Maria-Christina
Gerken, Guido
Antoni, Christoph
Doss, Margareta Frank
Schober, Andreas
Hoffstadt, Martin
Lucadou, Armand v.
Steffens, Hermann
Klinker, Hartwig
Geier, Andreas
Klausen, Gerd
Buggisch, Peter
Cornberg, Markus
Sarrazin, Christoph
Manns, Michael P.
Niederau, Claus
Protzer, Ulla
Schirmacher, Peter
,
Article History
First Online: 7 August 2018
Compliance with Ethical Standards
:
: GD: Speaker for AbbVie. TM: Consultancies: MERZ, AbbVie, MSD, Roche, BMS, Bayer, Intercept, and Gilead; speaker: MERZ; grants: Deutsche Forschungsgemeinschaft, Falk Foundation, and Intercept. JP: Grant/research support: BMS, Novartis, and Roche; clinical studies: AbbVie, Arrowhead, BMS, Eisai, Falk, Gilead, Hepatera, Hologic, Intercept, Janssen, Merck, MSD, Roche, Siemens, and Vertex; consultant/advisor: Abbott, AbbVie, Arrowhead, Assembly Pharma, BMS, Contravir, Gilead, GSK, Kedrion, Janssen, Merck, MSD, Novira, and Roche; sponsored lectures: Abbott, BMS, Boehringer, Gilead, Kedrion, Janssen, Merck, Merz, MSD, Novartis, and Roche. SM: Advisory committees or review panels: AbbVie, and MSD; speaker: AbbVie, Janssen, Gilead, and MSD. TZ: Received lecturer, consultant fees and/or travel support from AbbVie, BMS, Gilead, Janssen, MSD and Roche; grant: BMS. MM: Advisory committees: Bayer; speaker: Intercept and BMS; travel grants: AbbVie, Gilead, MSD, and Roche. KGS: Consultancies: AbbVie, Janssen, BMS, and MSD; speaker: Falk, AbbVie, Gilead, BMS, Janssen, Norgine, Merz, and MSD. TB: Speaker: AbbVie, Alexion, Bayer, BMS, Gilead, Intercept, Janssen, MSD/Merck, Merz, Novartis, Sirtex and Sequana Medical; grants: AbbVie, BMS, Gilead, Intercept, Janssen, MSD/Merck, Merz, Novartis, and Sequana Medical; adviser: AbbVie, Alexion, Bayer, BMS, Gilead, Intercept, Janssen, MSD/Merck, Merz, Novartis, and Sequana Medical. SZ: Consultancies/speaker for AbbVie, BMS, Gilead, Janssen, and Merck/MSD. DH: Advisor: Novartis, Gilead, BMS, Janssen, AbbVie, Roche, and MSD. KB: Speaker: MSD, Gilead, BMS and Roche. HW: Advisor: Falk, AbbVie, Novartis, Roche Diagnostics, Eiger, Janssen, GSK, Transgene, MSD, Roche, Gilead, Abbott, and BMS; consultancies: MyrGmbH; grants: Roche Diagnostics, Novartis, Gilead, Roche, Abbott, and MSD; speaker: AbbVie, Gilead, BMS, MSD, Novartis, and ITF. TMW: Consultancies/speaker for AbbVie, Bristol-Myers Squibb, Gilead, and Janssen.
Free to read: This content has been made available to all.